Pain Management Therapeutics Market Growth Report and Size by 2031
The Pain Management Therapeutics Market is expected to register a CAGR of 7.3% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, and Others); Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture and Other); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Pain Management Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Pain Management Therapeutics Market Segmentation
Drug Class- NSAIDS
- Anesthetics
- Anticonvulsant
- Anti-Migraine Drugs
- Antidepressant Drugs
- Opioids
- Others
- Arthritic Pain
- Neuropathic Pain
- Cancer Pain
- Chronic Pain
- Post-Operative Pain
- Migraine
- Fibromyalgia
- Bone Fracture and Other
- Hospital Pharmacies
- Retail Pharmacies and Online Pharmacies
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Pain Management Therapeutics Market Growth Drivers- Global chronic pain trend: Chronic pains like arthritis as well as other types of back pain or neuropathic pains have become one of the most important market drivers of pain management. An increase in the aged population worldwide as well as rising lifestyle diseases makes more and more people explore the best possible pain relief. This increasing demand makes good scope for developing advanced therapies and products in the arena of pain management.
- Technological advancements in Pain Relief: Other very new technologies are coming out with innovative devices to provide treatment in neuromodulation devices, TENS, and laser therapies-expanding treatment options in pain management. Such innovative technology will provide a non-invasive and targeted relief with lesser side effects as compared to medication.
- Emerging Effective Treatment and Personalized Treatment Will Attract Patients and Providers: With a rising marketplace, improved efficiency, and personalized therapy, patients and providers alike would be drawn to it. Transitioning from Opioids to Non-Opioid Options to Address the Opioid Crisis. The opioid crisis has propelled the entire world toward seeking alternatives for pain relief. More so, the growing prevalence of addictions and other misuse scenarios heightens such anxiety for patients and healthcare practitioners: Psychotherapy, Cognitive behavior therapy, etc. Without any addictive alternatives like acupuncture or topical analgesics, there has been such mammoth growth in provision for more holistic, opioid-free ways for patients, as well as a safe, more sustainable practice route for medical professionals to adopt.
- Use of Digital Health Technologies: Such digital health tools, like wearable devices and mobile applications, are changing the face of pain management, mainly with use. Device and smartphone application use enables patients to follow their intensity of pain while taking medications or on the post-taking-analyzing period of such measurements leading to health providers. It will increase patient engagement in their care, adherence to their treatments, and in the market size of digital pain management.
- Non-invasive Pain Management Techniques: Currently, being incorporated into the market for pain management, minimally invasive methods include radiofrequency ablation, epidural steroid injections, and peripheral nerve stimulators. These interventions are directed at pain reduction and are associated with less chance of injury, shorter recovery period, and fewer side effects compared with conventional surgical techniques. Thus, a growth in demand for minimally invasive solutions for pain management would thus be experienced because more patients seek such advanced treatments.
- An Expansion of Telemedicine for Pain Management: Telemedicine creates an entry point for pain management into remote pain consultations and virtual pain monitoring. Pain specialists can be accessed through the interaction of the patients at home, thus making treatment more accessible for patients in rural or underserved areas. Virtual rehabilitation and distance chronic pain management can reduce healthcare costs, improve clinical outcomes, and increase the demand for digital-based pain management solutions.
- Alternatives Increasing Non-Opioid Pain Relief: An enormous opportunity is in the development of non-opioid alternatives to manage the situation, given that the crisis is heightening the demands for much safer options. Products based on CBD, topical analgesics, as well as biologic therapies are gaining steam. Companies that invest in such alternatives would be on their way to capturing a rapidly expanding market in patients looking for alternative ways to relieve pain without the dangers associated with opioids.
- Preventative Pain Management: Demand increases toward chronic pain prevention because of the consciousness about conditions of chronic pain: lifestyle modification programs, coupled with physical therapy and early interventions, are gaining popularity; thus, the window for companies coming up with integrated solutions is open, preventing entry onset of pain and reducing the duration of treatments.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pain Management Therapeutics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Pain Management Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
NOVARTIS AG, ELI LILLY AND COMPANY, ABBOTT LABORATORIES, ENDO HEALTH SOLUTIONS, INC, PURDUE PHARMA L.P.
Use of Digital Health Technologies is likely to remain the key trend during the forecast period.
The market drivers include the Global chronic pain trend, Technological advancements in Pain Relief, Emerging Effective Treatment and Personalized Treatment Will Attract Patients and Providers
North America dominated the Pain Management Therapeutics Market in 2023
Asia Pacific region is likely to witness the fastest growth rate during the forecast period.
The Pain Management Therapeutics Market is estimated to witness a CAGR of 7.3% from 2023 to 2031
Table of Content
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pain Management Therapeutics Market - By Drug Class
1.3.2 Pain Management Therapeutics Market - By Indication
1.3.3 Pain Management Therapeutics Market - By Distribution Channel
1.3.4 Pain Management Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PAIN MANAGEMENT THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PAIN MANAGEMENT THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PAIN MANAGEMENT THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PAIN MANAGEMENT THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. PAIN MANAGEMENT THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2030
6.3. MARKET POSITIONING
7. PAIN MANAGEMENT THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2030 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NSAIDS
7.3.1. Overview
7.3.2. NSAIDS Market Forecast and Analysis
7.4. ANESTHETICS
7.4.1. Overview
7.4.2. Anesthetics Market Forecast and Analysis
7.5. ANTICONVULSANT
7.5.1. Overview
7.5.2. Anticonvulsant Market Forecast and Analysis
7.6. ANTI-MIGRAINE DRUGS
7.6.1. Overview
7.6.2. Anti-Migraine Drugs Market Forecast and Analysis
7.7. ANTIDEPRESSANT DRUGS
7.7.1. Overview
7.7.2. Antidepressant Drugs Market Forecast and Analysis
7.8. OPIOIDS
7.8.1. Overview
7.8.2. Opioids Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. PAIN MANAGEMENT THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2030 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. ARTHRITIC PAIN
8.3.1. Overview
8.3.2. Arthritic Pain Market Forecast and Analysis
8.4. NEUROPATHIC PAIN
8.4.1. Overview
8.4.2. Neuropathic Pain Market Forecast and Analysis
8.5. CANCER PAIN
8.5.1. Overview
8.5.2. Cancer Pain Market Forecast and Analysis
8.6. CHRONIC PAIN
8.6.1. Overview
8.6.2. Chronic Pain Market Forecast and Analysis
8.7. POST-OPERATIVE PAIN
8.7.1. Overview
8.7.2. Post-Operative Pain Market Forecast and Analysis
8.8. MIGRAINE
8.8.1. Overview
8.8.2. Migraine Market Forecast and Analysis
8.9. FIBROMYALGIA
8.9.1. Overview
8.9.2. Fibromyalgia Market Forecast and Analysis
8.10. BONE FRACTURE
8.10.1. Overview
8.10.2. Bone Fracture Market Forecast and Analysis
8.11. OTHER
8.11.1. Overview
8.11.2. Other Market Forecast and Analysis
9. PAIN MANAGEMENT THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2030 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. PAIN MANAGEMENT THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2030 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pain Management Therapeutics Market Overview
10.1.2 North America Pain Management Therapeutics Market Forecasts and Analysis
10.1.3 North America Pain Management Therapeutics Market Forecasts and Analysis - By Drug Class
10.1.4 North America Pain Management Therapeutics Market Forecasts and Analysis - By Indication
10.1.5 North America Pain Management Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pain Management Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pain Management Therapeutics Market
10.1.6.1.1 United States Pain Management Therapeutics Market by Drug Class
10.1.6.1.2 United States Pain Management Therapeutics Market by Indication
10.1.6.1.3 United States Pain Management Therapeutics Market by Distribution Channel
10.1.6.2 Canada Pain Management Therapeutics Market
10.1.6.2.1 Canada Pain Management Therapeutics Market by Drug Class
10.1.6.2.2 Canada Pain Management Therapeutics Market by Indication
10.1.6.2.3 Canada Pain Management Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Pain Management Therapeutics Market
10.1.6.3.1 Mexico Pain Management Therapeutics Market by Drug Class
10.1.6.3.2 Mexico Pain Management Therapeutics Market by Indication
10.1.6.3.3 Mexico Pain Management Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pain Management Therapeutics Market Overview
10.2.2 Europe Pain Management Therapeutics Market Forecasts and Analysis
10.2.3 Europe Pain Management Therapeutics Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Pain Management Therapeutics Market Forecasts and Analysis - By Indication
10.2.5 Europe Pain Management Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pain Management Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pain Management Therapeutics Market
10.2.6.1.1 Germany Pain Management Therapeutics Market by Drug Class
10.2.6.1.2 Germany Pain Management Therapeutics Market by Indication
10.2.6.1.3 Germany Pain Management Therapeutics Market by Distribution Channel
10.2.6.2 France Pain Management Therapeutics Market
10.2.6.2.1 France Pain Management Therapeutics Market by Drug Class
10.2.6.2.2 France Pain Management Therapeutics Market by Indication
10.2.6.2.3 France Pain Management Therapeutics Market by Distribution Channel
10.2.6.3 Italy Pain Management Therapeutics Market
10.2.6.3.1 Italy Pain Management Therapeutics Market by Drug Class
10.2.6.3.2 Italy Pain Management Therapeutics Market by Indication
10.2.6.3.3 Italy Pain Management Therapeutics Market by Distribution Channel
10.2.6.4 Spain Pain Management Therapeutics Market
10.2.6.4.1 Spain Pain Management Therapeutics Market by Drug Class
10.2.6.4.2 Spain Pain Management Therapeutics Market by Indication
10.2.6.4.3 Spain Pain Management Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Pain Management Therapeutics Market
10.2.6.5.1 United Kingdom Pain Management Therapeutics Market by Drug Class
10.2.6.5.2 United Kingdom Pain Management Therapeutics Market by Indication
10.2.6.5.3 United Kingdom Pain Management Therapeutics Market by Distribution Channel
10.2.6.6 Rest of Europe Pain Management Therapeutics Market
10.2.6.6.1 Rest of Europe Pain Management Therapeutics Market by Drug Class
10.2.6.6.2 Rest of Europe Pain Management Therapeutics Market by Indication
10.2.6.6.3 Rest of Europe Pain Management Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pain Management Therapeutics Market Overview
10.3.2 Asia-Pacific Pain Management Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Pain Management Therapeutics Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Pain Management Therapeutics Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Pain Management Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pain Management Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pain Management Therapeutics Market
10.3.6.1.1 Australia Pain Management Therapeutics Market by Drug Class
10.3.6.1.2 Australia Pain Management Therapeutics Market by Indication
10.3.6.1.3 Australia Pain Management Therapeutics Market by Distribution Channel
10.3.6.2 China Pain Management Therapeutics Market
10.3.6.2.1 China Pain Management Therapeutics Market by Drug Class
10.3.6.2.2 China Pain Management Therapeutics Market by Indication
10.3.6.2.3 China Pain Management Therapeutics Market by Distribution Channel
10.3.6.3 India Pain Management Therapeutics Market
10.3.6.3.1 India Pain Management Therapeutics Market by Drug Class
10.3.6.3.2 India Pain Management Therapeutics Market by Indication
10.3.6.3.3 India Pain Management Therapeutics Market by Distribution Channel
10.3.6.4 Japan Pain Management Therapeutics Market
10.3.6.4.1 Japan Pain Management Therapeutics Market by Drug Class
10.3.6.4.2 Japan Pain Management Therapeutics Market by Indication
10.3.6.4.3 Japan Pain Management Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Pain Management Therapeutics Market
10.3.6.5.1 South Korea Pain Management Therapeutics Market by Drug Class
10.3.6.5.2 South Korea Pain Management Therapeutics Market by Indication
10.3.6.5.3 South Korea Pain Management Therapeutics Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Pain Management Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific Pain Management Therapeutics Market by Drug Class
10.3.6.6.2 Rest of Asia-Pacific Pain Management Therapeutics Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Pain Management Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pain Management Therapeutics Market Overview
10.4.2 Middle East and Africa Pain Management Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Pain Management Therapeutics Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Pain Management Therapeutics Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Pain Management Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pain Management Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pain Management Therapeutics Market
10.4.6.1.1 South Africa Pain Management Therapeutics Market by Drug Class
10.4.6.1.2 South Africa Pain Management Therapeutics Market by Indication
10.4.6.1.3 South Africa Pain Management Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Pain Management Therapeutics Market
10.4.6.2.1 Saudi Arabia Pain Management Therapeutics Market by Drug Class
10.4.6.2.2 Saudi Arabia Pain Management Therapeutics Market by Indication
10.4.6.2.3 Saudi Arabia Pain Management Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Pain Management Therapeutics Market
10.4.6.3.1 U.A.E Pain Management Therapeutics Market by Drug Class
10.4.6.3.2 U.A.E Pain Management Therapeutics Market by Indication
10.4.6.3.3 U.A.E Pain Management Therapeutics Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Pain Management Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa Pain Management Therapeutics Market by Drug Class
10.4.6.4.2 Rest of Middle East and Africa Pain Management Therapeutics Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Pain Management Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pain Management Therapeutics Market Overview
10.5.2 South and Central America Pain Management Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Pain Management Therapeutics Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Pain Management Therapeutics Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Pain Management Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pain Management Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pain Management Therapeutics Market
10.5.6.1.1 Brazil Pain Management Therapeutics Market by Drug Class
10.5.6.1.2 Brazil Pain Management Therapeutics Market by Indication
10.5.6.1.3 Brazil Pain Management Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Pain Management Therapeutics Market
10.5.6.2.1 Argentina Pain Management Therapeutics Market by Drug Class
10.5.6.2.2 Argentina Pain Management Therapeutics Market by Indication
10.5.6.2.3 Argentina Pain Management Therapeutics Market by Distribution Channel
10.5.6.3 Rest of South and Central America Pain Management Therapeutics Market
10.5.6.3.1 Rest of South and Central America Pain Management Therapeutics Market by Drug Class
10.5.6.3.2 Rest of South and Central America Pain Management Therapeutics Market by Indication
10.5.6.3.3 Rest of South and Central America Pain Management Therapeutics Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PAIN MANAGEMENT THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. NOVARTIS AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ELI LILLY AND COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ABBOTT LABORATORIES
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ENDO HEALTH SOLUTIONS, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PURDUE PHARMA L.P.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PFIZER, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MYLAN NV.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK AND CO. INC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. JOHNSON AND JOHNSON
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. GLAXOSMITHKLINE PLC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. NOVARTIS AG
2. ELI LILLY AND COMPANY
3. ABBOTT LABORATORIES
4. ENDO HEALTH SOLUTIONS, INC
5. PURDUE PHARMA L.P.
6. PFIZER, INC.
7. MYLAN NV.
8. MERCK AND CO. INC
9. JOHNSON AND JOHNSON
10. GLAXOSMITHKLINE PLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For